Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China

Authors: Zhengrong Sun, Zhitao Lu, Jianhua Liu, Guili Wang, Weiqiang Zhou, Lianxia Yang, Chao Liu, Bo Wang, Qiang Ruan

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

High-risk human papillomavirus type 16 (HPV16) is a risk factor for cervical cancer. Previous studies suggest that polymorphisms in the E6 gene or the long control region(LCR)of HPV16 may alter the oncogenic potential of the virus. The aims of this study were to investigate the genetic variations of HPV16 E6 gene and LCR in isolates from Chinese population and correlation of the E6 and LCR polymorphisms with disease status of infected patients.

Methods

HPV16 positive endocervical specimens were collected from 304 women living in Northeast of China. Sequences of E6 gene and LCR were analyzed by PCR-sequencing.

Results

Two lineages were found in the populations, including EUR lineage and As lineage. Based on the HPV16 prototype, the most frequent variation in the E6 gene was T178A/G (48.7%), followed by mutations of G94A (12.2%) and T350G (9.9%). The rank orders of incidence of E6 variations in amino acid were as follows: D25E (46.3%), L83V (9.9%) and H78Y (4.3%). Nucleotide variations in LCR were found in all the 304 isolates from HPV16 positive cervical samples. The most commonly observed LCR variations were the transition replacement G7193T, 7434CIns, G7521A and 7863ADel (100%). The As lineage was associated with HPV persistent infections and with disease status of ≥CIN2,3. The EUR lineage variants showed a negative trend of association with the severity of ≥CIN2,3. Among 41 variations found in LCR, 25 (61.0%) were located at the binding sites for transcription factors. Occurrence of ≥CIN2,3 was significantly associated with the mutations of R10G/L83V in E6 and the C7294T co-variation in LCR, after adjusting for ages of infected patients.

Conclusions

Associations between As lineage and HPV persistent infections, and with disease status of ≥CIN2,3, and an association between the EUR lineage and negative trend of association with the severity of ≥CIN2,3 were found in this study. An association between a co-variation of R10G/L83V in E6 and C7294T in LCR and an increased risk for developing CIN-2,3 was found in a HPV16 infected population of Chinese women. These findings indicate that HPV16 polymorphism influences development of CIN-2,3.
Literature
1.
go back to reference Ferenczy A, Franco EL: Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002, 3: 11-16. 10.1016/S1470-2045(01)00617-9.CrossRefPubMed Ferenczy A, Franco EL: Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002, 3: 11-16. 10.1016/S1470-2045(01)00617-9.CrossRefPubMed
2.
go back to reference Wang SS, Hildesheim A: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003, 31: 35-40.CrossRefPubMed Wang SS, Hildesheim A: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003, 31: 35-40.CrossRefPubMed
3.
go back to reference Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD: Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol. 2005, 79 (11): 7014-7023. 10.1128/JVI.79.11.7014-7023.2005.CrossRefPubMedPubMedCentral Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD: Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol. 2005, 79 (11): 7014-7023. 10.1128/JVI.79.11.7014-7023.2005.CrossRefPubMedPubMedCentral
4.
go back to reference Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006, 118: 1071-1076. 10.1002/ijc.21655.CrossRefPubMed Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006, 118: 1071-1076. 10.1002/ijc.21655.CrossRefPubMed
5.
go back to reference Giannoudis A, Herrington CS: Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol. 2001, 193: 295-302. 10.1002/1096-9896(2000)9999:9999<::AID-PATH809>3.0.CO;2-C.CrossRefPubMed Giannoudis A, Herrington CS: Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol. 2001, 193: 295-302. 10.1002/1096-9896(2000)9999:9999<::AID-PATH809>3.0.CO;2-C.CrossRefPubMed
6.
go back to reference Sun ZR, Ji YH, Zhou WQ, Zhang SL, Jiang WG, Ruan Q: Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet. 2010, 109: 105-109. 10.1016/j.ijgo.2009.11.026.CrossRefPubMed Sun ZR, Ji YH, Zhou WQ, Zhang SL, Jiang WG, Ruan Q: Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet. 2010, 109: 105-109. 10.1016/j.ijgo.2009.11.026.CrossRefPubMed
7.
go back to reference Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervicalcancers worldwide: Variation by geographical region, histologicaltype and year of publication. Int J Cancer. 2011, 128: 927-935. 10.1002/ijc.25396.CrossRefPubMed Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervicalcancers worldwide: Variation by geographical region, histologicaltype and year of publication. Int J Cancer. 2011, 128: 927-935. 10.1002/ijc.25396.CrossRefPubMed
8.
go back to reference Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang T, et al: Sequence imputation of HPV16 genomes for genetic association studies. PLoS One. 2011, 6: e21375-10.1371/journal.pone.0021375.CrossRefPubMedPubMedCentral Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang T, et al: Sequence imputation of HPV16 genomes for genetic association studies. PLoS One. 2011, 6: e21375-10.1371/journal.pone.0021375.CrossRefPubMedPubMedCentral
9.
go back to reference Gheit T, Cornet I, Clifford GM, Iftner T, Munk C, Tommasino M, Kjaer SK: Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol Biomarkers Prev. 2011, 20: 1315-1321. 10.1158/1055-9965.EPI-10-1187.CrossRefPubMed Gheit T, Cornet I, Clifford GM, Iftner T, Munk C, Tommasino M, Kjaer SK: Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol Biomarkers Prev. 2011, 20: 1315-1321. 10.1158/1055-9965.EPI-10-1187.CrossRefPubMed
10.
go back to reference Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB: Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007, 16: 4-10. 10.1158/1055-9965.EPI-06-0670.CrossRefPubMed Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB: Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007, 16: 4-10. 10.1158/1055-9965.EPI-06-0670.CrossRefPubMed
11.
go back to reference Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T: Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer. 2009, 125: 2609-2613. 10.1002/ijc.24706.CrossRefPubMedPubMedCentral Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T: Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer. 2009, 125: 2609-2613. 10.1002/ijc.24706.CrossRefPubMedPubMedCentral
12.
go back to reference Sun Z, Lu Z, Liu J, Wang G, Zhou W, Yang L, Liu C, Ruan Q: Genomic polymorphism of human papillomavirus type 52 in women from Northeast China. Int J Mol Sci. 2012, 13: 14962-14972. 10.3390/ijms131114962.CrossRefPubMedPubMedCentral Sun Z, Lu Z, Liu J, Wang G, Zhou W, Yang L, Liu C, Ruan Q: Genomic polymorphism of human papillomavirus type 52 in women from Northeast China. Int J Mol Sci. 2012, 13: 14962-14972. 10.3390/ijms131114962.CrossRefPubMedPubMedCentral
13.
go back to reference Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM, IARC HPV Variant Study Group: Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol. 2012, 86: 6855-6861. 10.1128/JVI.00483-12.CrossRefPubMedPubMedCentral Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM, IARC HPV Variant Study Group: Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol. 2012, 86: 6855-6861. 10.1128/JVI.00483-12.CrossRefPubMedPubMedCentral
14.
go back to reference Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA: Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995, 69: 7743-7753.PubMedPubMedCentral Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA: Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995, 69: 7743-7753.PubMedPubMedCentral
15.
go back to reference Cornet I, Gheit T, Iannacone MR, Vignat J, Sylla BS, Del Mistro A, Franceschi S, Tommasino M, Clifford GM: HPV16 genetic variation and the development of cervical cancer worldwide. Br J Cancer. 2013, 108: 240-244. 10.1038/bjc.2012.508.CrossRefPubMed Cornet I, Gheit T, Iannacone MR, Vignat J, Sylla BS, Del Mistro A, Franceschi S, Tommasino M, Clifford GM: HPV16 genetic variation and the development of cervical cancer worldwide. Br J Cancer. 2013, 108: 240-244. 10.1038/bjc.2012.508.CrossRefPubMed
16.
go back to reference Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, et al: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl Acids Res. 1998, 26: 362-367. 10.1093/nar/26.1.362.CrossRefPubMedPubMedCentral Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, et al: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl Acids Res. 1998, 26: 362-367. 10.1093/nar/26.1.362.CrossRefPubMedPubMedCentral
17.
go back to reference Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL: Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000, 81: 2959-2968.CrossRefPubMed Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL: Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000, 81: 2959-2968.CrossRefPubMed
18.
go back to reference Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, et al: Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004, 74: 117-126. 10.1002/jmv.20154.CrossRefPubMed Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, et al: Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004, 74: 117-126. 10.1002/jmv.20154.CrossRefPubMed
19.
go back to reference Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL: High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007, 120: 1763-1768. 10.1002/ijc.22481.CrossRefPubMed Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL: High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007, 120: 1763-1768. 10.1002/ijc.22481.CrossRefPubMed
20.
go back to reference Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A: A sian–American variants of human papillomavirus 16 and risk for cervical cancer: a case–control study. J Natl Cancer Inst. 2001, 93: 1325-1330. 10.1093/jnci/93.17.1325.CrossRefPubMed Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A: A sian–American variants of human papillomavirus 16 and risk for cervical cancer: a case–control study. J Natl Cancer Inst. 2001, 93: 1325-1330. 10.1093/jnci/93.17.1325.CrossRefPubMed
21.
go back to reference Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, et al: Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001, 93: 315-318. 10.1093/jnci/93.4.315.CrossRefPubMed Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, et al: Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001, 93: 315-318. 10.1093/jnci/93.4.315.CrossRefPubMed
22.
go back to reference Lizano M, De la Cruz-Hernández E, Carrillo-García A, García-Carrancá A, Ponce de Leon-Rosales S, Dueñas-González A, Hernández-Hernández DM, Mohar A: Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican popul ation. Gynecol Oncol. 2006, 102: 230-235. 10.1016/j.ygyno.2005.12.002.CrossRefPubMed Lizano M, De la Cruz-Hernández E, Carrillo-García A, García-Carrancá A, Ponce de Leon-Rosales S, Dueñas-González A, Hernández-Hernández DM, Mohar A: Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican popul ation. Gynecol Oncol. 2006, 102: 230-235. 10.1016/j.ygyno.2005.12.002.CrossRefPubMed
23.
go back to reference Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I: Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev. 2006, 15: 820-822. 10.1158/1055-9965.EPI-05-0864.CrossRefPubMed Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I: Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev. 2006, 15: 820-822. 10.1158/1055-9965.EPI-05-0864.CrossRefPubMed
24.
go back to reference Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I: Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res. 2008, 131: 106-110. 10.1016/j.virusres.2007.08.003.CrossRefPubMed Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I: Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res. 2008, 131: 106-110. 10.1016/j.virusres.2007.08.003.CrossRefPubMed
25.
go back to reference Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, et al: Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol. 2005, 79: 13630-13640. 10.1128/JVI.79.21.13630-13640.2005.CrossRefPubMedPubMedCentral Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, et al: Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol. 2005, 79: 13630-13640. 10.1128/JVI.79.21.13630-13640.2005.CrossRefPubMedPubMedCentral
26.
go back to reference Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD: Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One. 2011, 6: e20183-10.1371/journal.pone.0020183.CrossRefPubMedPubMedCentral Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD: Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One. 2011, 6: e20183-10.1371/journal.pone.0020183.CrossRefPubMedPubMedCentral
27.
go back to reference Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, Batra S, Das BC: Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol. 2008, 46: 1060-1066. 10.1128/JCM.02202-07.CrossRefPubMedPubMedCentral Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, Batra S, Das BC: Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol. 2008, 46: 1060-1066. 10.1128/JCM.02202-07.CrossRefPubMedPubMedCentral
28.
go back to reference Gagnon S, Hankins C, Tremblay C, Forest P, Pourreaux K, Coutlée F, Canadian Women's HIV Study Group: Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J Infect Dis. 2004, 190: 1575-1585. 10.1086/424854.CrossRefPubMed Gagnon S, Hankins C, Tremblay C, Forest P, Pourreaux K, Coutlée F, Canadian Women's HIV Study Group: Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J Infect Dis. 2004, 190: 1575-1585. 10.1086/424854.CrossRefPubMed
29.
go back to reference Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA: Human papillomavirus type 16 and 18 variants: race related distribution and persistence. J Natl Cancer Inst. 2006, 98: 1045-1052. 10.1093/jnci/djj297.CrossRefPubMed Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA: Human papillomavirus type 16 and 18 variants: race related distribution and persistence. J Natl Cancer Inst. 2006, 98: 1045-1052. 10.1093/jnci/djj297.CrossRefPubMed
30.
go back to reference Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, et al: Human papillomavirus type 33 polymorphism and highgrade lesions of the uterine cervix. J Inf Dis. 2006, 194: 886-894. 10.1086/507431.CrossRef Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, et al: Human papillomavirus type 33 polymorphism and highgrade lesions of the uterine cervix. J Inf Dis. 2006, 194: 886-894. 10.1086/507431.CrossRef
31.
go back to reference Hubert WG: Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol. 2005, 79: 5914-5922. 10.1128/JVI.79.10.5914-5922.2005.CrossRefPubMedPubMedCentral Hubert WG: Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol. 2005, 79: 5914-5922. 10.1128/JVI.79.10.5914-5922.2005.CrossRefPubMedPubMedCentral
32.
go back to reference Kyo S, Klumpp DJ, Inoue M, Kanaya T, Laimins LA: Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol. 1997, 78: 401-411.CrossRefPubMed Kyo S, Klumpp DJ, Inoue M, Kanaya T, Laimins LA: Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol. 1997, 78: 401-411.CrossRefPubMed
33.
go back to reference O’Connor M, Bernard HU: Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virol. 1995, 207: 77-88. 10.1006/viro.1995.1053.CrossRef O’Connor M, Bernard HU: Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virol. 1995, 207: 77-88. 10.1006/viro.1995.1053.CrossRef
34.
go back to reference Soeda E, Ferran MC, Baker CC, McBride AA: Repression of HPV16 early region transcription by the E2 protein. Virology. 2006, 351 (1): 29-41. 10.1016/j.virol.2006.03.016.CrossRefPubMed Soeda E, Ferran MC, Baker CC, McBride AA: Repression of HPV16 early region transcription by the E2 protein. Virology. 2006, 351 (1): 29-41. 10.1016/j.virol.2006.03.016.CrossRefPubMed
Metadata
Title
Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China
Authors
Zhengrong Sun
Zhitao Lu
Jianhua Liu
Guili Wang
Weiqiang Zhou
Lianxia Yang
Chao Liu
Bo Wang
Qiang Ruan
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-459

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine